mirror of
https://github.com/genodelabs/genode.git
synced 2025-02-22 10:21:04 +00:00
News item about the license update to AGPLv3
This commit is contained in:
parent
db0dc0d97c
commit
8b4afe95c1
35
doc/news.txt
35
doc/news.txt
@ -4,6 +4,41 @@
|
|||||||
===========
|
===========
|
||||||
|
|
||||||
|
|
||||||
|
Open-source license update | 2017-02-21
|
||||||
|
#######################################
|
||||||
|
|
||||||
|
| With the upcoming version 17.02, Genode will adopt the GNU Affero General
|
||||||
|
| Public License (AGPLv3) as its regular open-source license.
|
||||||
|
|
||||||
|
Since our first release in 2008, Genode has been available under two flavors
|
||||||
|
of licenses addressing different user bases. With Genode's regular open-source
|
||||||
|
license, we address the Free-Software community, researchers, and technology
|
||||||
|
enthusiasts. With the commercial license, Genode Labs enables product vendors
|
||||||
|
to leverage Genode's technology for their businesses.
|
||||||
|
|
||||||
|
For our open-source license, we originally picked the time-tested GNU General
|
||||||
|
Public License version 2 (GPLv2). However, the time did not stand still. After
|
||||||
|
9 years, it is time to update the license to a more recent version. After
|
||||||
|
careful review of the open-source licensing landscape, we settled on the GNU
|
||||||
|
Affero General Public License (AGPLv3), which is based on the GNU GPLv3 and
|
||||||
|
thereby rectifies several shortcomings of the GPLv2. Furthermore, it closes
|
||||||
|
loopholes of the GPLv3 license with respect to web applications. Unlike 2008
|
||||||
|
when most applications were programs executed directly on the end user's
|
||||||
|
computer, web applications have become predominant by now.
|
||||||
|
|
||||||
|
To address possible concerns about the interoperability of the AGPLv3 with
|
||||||
|
other open-source licenses, Genode's license will be accompanied with a
|
||||||
|
linking-exception clause that clarifies our consent to link Genode with all
|
||||||
|
commonly established open-source licenses.
|
||||||
|
|
||||||
|
In December, we presented our plan of the license change to the subscribers of
|
||||||
|
Genode's mailing list. The following constructive
|
||||||
|
[https://sourceforge.net/p/genode/mailman/genode-main/thread/585116C8.2020607%40genode-labs.com/#msg35550569 - discussion]
|
||||||
|
within the community helped us to refine our linking clause and to create a
|
||||||
|
common understanding of the rationale behind our licensing choice. Thanks to
|
||||||
|
everyone who participated in this discussion!
|
||||||
|
|
||||||
|
|
||||||
Road Map for 2017 | 2017-01-17
|
Road Map for 2017 | 2017-01-17
|
||||||
##############################
|
##############################
|
||||||
|
|
||||||
|
Loading…
x
Reference in New Issue
Block a user